23 Jan 2007 |
Hikma expands into the oncology market
|
20 Jan 2007 |
Penwest Begins Next Study in Development of Nalbuphine ER
|
20 Jan 2007 |
Bayer Schering Pharma to develop new imaging compounds for detection of Neurodegenerative Diseases
|
19 Jan 2007 |
Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
|
19 Jan 2007 |
Adherex Buys Out Eniluracil Development Options From GlaxoSmithKline
|
19 Jan 2007 |
Barr Laboratories Receives Tentative Approval For Generic KYTRIL(R) Tablets, 1mg (Base)
|
18 Jan 2007 |
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
|
18 Jan 2007 |
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
|
18 Jan 2007 |
XOMA and Schering-Plough Add New Programs to Antibody Collaboration
|
17 Jan 2007 |
Hana Biosciences Receives Orphan Drug Designation for Marqibo (Vincristine Sulfate Liposomes Injection) for the Treatment of Acute Lymphoblastic Leukemia
|
17 Jan 2007 |
Genizon Biosciences Announces a License and Collaboration Agreement with Pfizer in Three Major Diseases
|
17 Jan 2007 |
DOV Pharmaceutical Announces Exclusive Agreement for the Development and Commercialization of Bicifadine
|
17 Jan 2007 |
Marketing License Granted in The Netherlands for Adult Patients with Depression
|
17 Jan 2007 |
DanioLabs and Senexis Announce Collaboration on Ageing Related Diseases
|
17 Jan 2007 |
Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
|
13 Jan 2007 |
Bioxell Acquires Novel Compound from Roche
|
13 Jan 2007 |
BioInvent enters collaboration with Genentech to develop and commercialize BioInvent's proprietary antibody for the potential treatment of cardiovascular diseases
|
13 Jan 2007 |
Nicholas Piramal announces Drug Development Agreement with Eli Lilly and Company.
|
13 Jan 2007 |
Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
|
13 Jan 2007 |
Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
|
12 Jan 2007 |
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
|
12 Jan 2007 |
Immuno-Biological Laboratories Co., Ltd. and Intellect Neurosciences, Inc. Enter into Humanized Monoclonal Antibodies Development Agreement for the Treatment of Alzheimer's Disease
|
12 Jan 2007 |
KINAXO Announces Agreement with Johnson & Johnson
|
12 Jan 2007 |
Wyeth and Solvay Enter Into an Additional Neuroscience Collaboration
|
11 Jan 2007 |
Organon and the Academic Medical Center jointly develop novel treatment of rheumatoid arthritis
|